|
|
Article: Biotechnology companies were the most common partners for diagnostics companies in alliance formation, accounting for 29% of all diagnostic alliance partners.
- Article from:
- M2 Presswire
- Article date:
- January 31, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-31 January 2006-Research and Markets: Biotechnology companies were the most common partners for diagnostics companies in alliance formation, accounting for 29% of all diagnostic alliance partners(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:31012006
Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c32004) has announced the addition of Diagnostics Dealmaking Activity - First Quarter 2004 to Third Quarter 2005 to their offering
The medical diagnostics industry is an important and fast-growing segment of the life sciences industry. The diagnostics companies included in this report range from makers of test kits to ...